ATP6AP2 and pancreatic insulinoma: Therefore, we analyzed the expression profiles of ATP6AP2 in pancreatic endocrine cells and insulinoma cells, and aimed to clarify whether the knockdown approach for Atp6ap2 can reduce the viability of insulinoma cells, which may lead to the development of novel therapeutic approaches.